TABLE 5-4 Funding for CAPM Firms

 

Year

2004/2005

2005/2006

Number of companies in CAP

114

114

Number receiving investments

24

13

Percent of total

21.1

11.4

Total investment to date

$22,414,078

$45,636,520

SOURCE: National Institutes of Health.

recipients. Using somewhat different methodologies from the NRC Phase II Survey, with concomitantly different strengths and weaknesses, the NIH Survey broke important ground, and provided results that have been used throughout this analysis.

Discussions with agency staff and responses to the NRC Program Manager Survey indicate widespread views that the program does not have the resources needed to develop an evaluation and assessment program sufficient to manage a program of this size and scope. Phil Daschner, from NCI, for example noted that “More resources should be available to program staff that track and evaluate objective benchmarks for past institutional and investigator productivity.” In its institutional response to the NRC survey, NCI observed that “we still do not have reliable tools to capture in an ongoing way success stories from our grantees. It is a considerable undertaking to get evaluation funds and go through the OMB process. Methods have been identified to capture outcomes, but funds are not

FIGURE 5-11 Aggregate number of partnership- and deal-related activities by category.

FIGURE 5-11 Aggregate number of partnership- and deal-related activities by category.

SOURCE: National Institutes of Health.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement